Episode Details
Back to Episodes
Key Viral Hepatitis Studies Influencing My Practice Following EASL 2022—Audio Recap
Episode 181
Published 3 years, 8 months ago
Description
In this episode, Stefan Zeuzem, MD, discusses new viral hepatitis data from EASL 2022, including:
- Novel HBV therapeutics, including the REEF-2, B-Clear, and SAVE-1 studies
- HBV cure from the Everest Project in China
- HDV therapeutics from MYR301 and a study of bulevirtide in patients with cirrhosis and portal hypertension
- HCV retreatment in patients with prior direct-acting antiviral therapy failure
Presenter:
Stefan Zeuzem, MD
Professor of Medicine
Chief, Department of Medicine I
JW Goethe University Hospital
Frankfurt, Germany
Follow along with the downloadable slideset at:
https://bit.ly/3yJAruD
Link to full program:
https://bit.ly/3AjCNBC
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.